from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2905/lppW

LFCtreatmentdescriptionclass of inhibitor

-0.790

Amikacinug/mL Amikacintranslation

0.740

Cap5-10ug/mL Capreomycintranslation

1.463

Rox10-50 ug/mL Roxithromycintranslation

-0.418

SM2-5 ug/mL Streptomycintranslation

0.541

Tet5-10 ug/mL Tetracyclinetranslation

-0.650

Rif0.2-5ug/mL Rifampicintranscription

0.166

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.297

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.302

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.180

CPZ10-50 ug/mL Chlorpromazinerespiration

0.300

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.640

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.859

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.082

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.523

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.404

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.230

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.139

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.060

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.433

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.868

KCN5-20 ug/mL Potassium cyaniderespiration

-0.464

NaN30.2-2 mM Sodium aziderespiration

0.426

Nigericin50 uM Nigericinrespiration

-0.081

TRC10-150 ug/mL Triclosanrespiration

-0.906

TRZ10-25 ug/mL Thioridazinerespiration

-1.613

Valinomycin0.5-10 uM Valinomycinrespiration

0.565

ZnSO42 mM ZnSO4respiration

0.652

menadione6-10 ug/mL Menadionerespiration

0.567

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.587

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.730

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.137

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.334

NRP_1Non-replicating persistence stage 1dosRassociated

0.582

Amp0.2mg/mL AmpicillincellWall

0.580

Cephalexin20-100 ug/mL CephalexincellWall

0.252

Cerulenin0.32-5 ug/mL CerulenincellWall

0.324

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.188

EMB10-20 ug/mL EthambutolcellWall

0.237

Eta12-40 ug/mL EthionamidecellWall

0.462

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.320

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.477

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.226

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.030

BZA0.12 mg/mL BenzamidearomaticAmides

-0.869

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.918

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.323

H2O24 mM hydrogen peroxideDNAdamaging

0.167

Levo10 ug/mL LevofloxacinDNAdamaging

-0.456

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.927

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.195

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.018

UVUV-irradiationDNAdamaging

2.467

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.099

Antimycin12.5-50 ug/mL Antimycin A?

0.498

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.033

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.358

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.121

PA8240.2-2 ug/mL PA-824?

1.460

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.499

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.104

Verapamil50 uM Verapamil?

0.107

mercaptoethanol2 mM 2-Mercaptoethanol?

0.428

methoxatin10-20 ug/mL Methoxatin?